Antonio Villaverde

13.8k total citations
348 papers, 10.5k citations indexed

About

Antonio Villaverde is a scholar working on Molecular Biology, Genetics and Ecology. According to data from OpenAlex, Antonio Villaverde has authored 348 papers receiving a total of 10.5k indexed citations (citations by other indexed papers that have themselves been cited), including 253 papers in Molecular Biology, 87 papers in Genetics and 76 papers in Ecology. Recurrent topics in Antonio Villaverde's work include Bacteriophages and microbial interactions (75 papers), RNA Interference and Gene Delivery (61 papers) and Bacterial Genetics and Biotechnology (56 papers). Antonio Villaverde is often cited by papers focused on Bacteriophages and microbial interactions (75 papers), RNA Interference and Gene Delivery (61 papers) and Bacterial Genetics and Biotechnology (56 papers). Antonio Villaverde collaborates with scholars based in Spain, Argentina and Germany. Antonio Villaverde's co-authors include Esther Vázquez, Mar Carrió, José Luís Corchero, Elena García‐Fruitós, Neus Ferrer‐Miralles, Ugutz Unzueta, Anna Arı́s, Salvador Ventura, Ramón Mangues and Núria González‐Montalbán and has published in prestigious journals such as Advanced Materials, Journal of Biological Chemistry and Nano Letters.

In The Last Decade

Antonio Villaverde

340 papers receiving 10.3k citations

Peers

Countries citing papers authored by Antonio Villaverde

Since Specialization

Citations

This map shows the geographic impact of Antonio Villaverde's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Antonio Villaverde with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Antonio Villaverde more than expected).

Fields of papers citing papers by Antonio Villaverde

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Antonio Villaverde. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Antonio Villaverde. The network helps show where Antonio Villaverde may publish in the future.

Co-authorship network of co-authors of Antonio Villaverde

This figure shows the co-authorship network connecting the top 25 collaborators of Antonio Villaverde. A scholar is included among the top collaborators of Antonio Villaverde based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Antonio Villaverde. Antonio Villaverde is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Subcutaneous administration of an endocrine-mimetic, slow-release protein material reduces the severity of SARS-CoV-2 infection 2025 ·Journal of Drug Delivery Science and Technology ·Eloi Parladé, Ferran Tarrés-Freixas, Marianna Teixeira de Pinho Favaro, (unknown), (unknown), Rosa Mendoza, José Luís Corchero, Guillermo Cantero, (unknown), Mónica Pérez, Neus Ferrer‐Miralles, Esther Vázquez, Joaquím Segalés, Júlia Vergara‐Alert, Antonio Villaverde	1
2	Trans-Mediated, Cis-Inhibited Paradoxal Activity of Clostridium perfringens Enterotoxin (c-CPE) in Modulating Epithelial Permeability 2025 ·Molecular Pharmaceutics ·Julieta M. Sánchez, Marianna Teixeira de Pinho Favaro, Hèctor López‐Laguna, Eloi Parladé, Angela Di Somma, Isolda Casanova, Ugutz Unzueta, Ramón Mangues, Esther Vázquez, Eric Voltà‐Durán, Antonio Villaverde	1
3	Structural Stabilization of Clinically Oriented Oligomeric Proteins During their Transit through Synthetic Secretory Amyloids 2024 ·Advanced Science ·Julieta M. Sánchez, Hèctor López‐Laguna, Eloi Parladé, Angela Di Somma, (unknown), Patricia Álamo, Ramón Mangues, Ugutz Unzueta, Antonio Villaverde, Esther Vázquez	10
4	Zinc-Assisted Microscale Granules Made of the SARS-CoV-2 Spike Protein Trigger Neutralizing, Antivirus Antibody Responses 2024 ·ACS Materials Letters ·Marianna Teixeira de Pinho Favaro, Patricia Álamo, Nerea Roher, Miguel Chillón, (unknown), M. Márquez, José Luís Corchero, Rosa Mendoza, (unknown), Neus Ferrer‐Miralles, Luís Carlos de Souza Ferreira, Ramón Mangues, Esther Vázquez, Eloi Parladé, Antonio Villaverde	6
5	High-precision targeting and destruction of cancer-associated PDGFR-β+ stromal fibroblasts through self-assembling, protein-only nanoparticles 2023 ·Acta Biomaterialia ·Eric Voltà‐Durán, Lorena Alba‐Castellón, Naroa Serna, Isolda Casanova, Hèctor López‐Laguna, Alberto Gallardo, Alejandro Sánchez‐Chardi, Antonio Villaverde, Ugutz Unzueta, Esther Vázquez, Ramón Mangues	4
6	Recombinant Proteins for Assembling as Nano- and Micro-Scale Materials for Drug Delivery: A Host Comparative Overview 2023 ·Pharmaceutics ·José Luís Corchero, Marianna Teixeira de Pinho Favaro, M. Márquez, (unknown), (unknown), Julieta M. Sánchez, Hèctor López‐Laguna, Luís Carlos de Souza Ferreira, Esther Vázquez, Neus Ferrer‐Miralles, Antonio Villaverde, Eloi Parladé	7
7	Probing the Biosafety of Implantable Artificial Secretory Granules for the Sustained Release of Bioactive Proteins 2023 ·ACS Applied Materials & Interfaces ·Patricia Álamo, Eloi Parladé, Marianna Teixeira de Pinho Favaro, Alberto Gallardo, Rosa Mendoza, Luís Carlos de Souza Ferreira, Nerea Roher, Ramón Mangues, Antonio Villaverde, Esther Vázquez	5
8	Biofabrication of Self-Assembling Covalent Protein Nanoparticles through Histidine-Templated Cysteine Coupling 2023 ·ACS Sustainable Chemistry & Engineering ·Hèctor López‐Laguna, (unknown), (unknown), (unknown), (unknown), (unknown), Eloi Parladé, Julieta M. Sánchez, Naroa Serna, Eric Voltà‐Durán, Neus Ferrer‐Miralles, David Reverter, Ramón Mangues, Antonio Villaverde, Esther Vázquez, Ugutz Unzueta	4
9	Efficient Delivery of Antimicrobial Peptides in an Innovative, Slow-Release Pharmacological Formulation 2023 ·Pharmaceutics ·Naroa Serna, Hèctor López‐Laguna, (unknown), (unknown), Eloi Parladé, Eric Voltà‐Durán, (unknown), Julieta M. Sánchez, Angela Di Somma, (unknown), (unknown), Neus Ferrer‐Miralles, Esther Vázquez, Ugutz Unzueta, Nerea Roher, Antonio Villaverde	9
10	A Novel CXCR4-Targeted Diphtheria Toxin Nanoparticle Inhibits Invasion and Metastatic Dissemination in a Head and Neck Squamous Cell Carcinoma Mouse Model 2022 ·Pharmaceutics ·(unknown), Alberto Gallardo, Irene Arroyo‐Solera, Patricia Álamo, Isolda Casanova, Ugutz Unzueta, Naroa Serna, Laura Sánchez‐García, Miquel Quer, Antonio Villaverde, Esther Vázquez, Xavier León, Lorena Alba‐Castellón, Ramón Mangues	9
11	The Diphtheria Toxin Translocation Domain Impairs Receptor Selectivity in Cancer Cell-Targeted Protein Nanoparticles 2022 ·Pharmaceutics ·Eric Voltà‐Durán, Julieta M. Sánchez, Eloi Parladé, Naroa Serna, Esther Vázquez, Ugutz Unzueta, Antonio Villaverde	4
12	The Potential of Metalloproteinase-9 Administration to Accelerate Mammary Involution and Boost the Immune System at Dry-Off 2021 ·Animals ·(unknown), Olivia Cano‐Garrido, À. Bach, Neus Ferrer‐Miralles, Antonio Villaverde, Elena García‐Fruitós, Anna Arı́s	3
13	Antibacterial Activity of T22, a Specific Peptidic Ligand of the Tumoral Marker CXCR4 2021 ·Pharmaceutics ·Naroa Serna, (unknown), Oscar Conchillo‐Solé, (unknown), Ugutz Unzueta, Ramón Mangues, Neus Ferrer‐Miralles, Xavier Daura, Esther Vázquez, Antonio Villaverde	9
14	In Vivo Bactericidal Efficacy of GWH1 Antimicrobial Peptide Displayed on Protein Nanoparticles, a Potential Alternative to Antibiotics 2020 ·Pharmaceutics ·(unknown), Éric Brouillette, Naroa Serna, Alejandro Sánchez‐Chardi, Julieta M. Sánchez, Antonio Villaverde, Anna Arı́s, Elena García‐Fruitós, Neus Ferrer‐Miralles, François Malouin	10
15	Recombinant Protein-Based Nanoparticles: Elucidating Their Inflammatory Effects In Vivo and Their Potential as a New Therapeutic Format 2020 ·Pharmaceutics ·(unknown), Estefanía Ugarte-Berzal, Erik Martens, (unknown), Olivia Cano‐Garrido, (unknown), Teresa Luque, (unknown), Oscar Conchillo‐Solé, Neus Ferrer‐Miralles, Antonio Villaverde, Ghislain Opdenakker, Elena García‐Fruitós, Anna Arı́s	7
16	The Biological Potential Hidden in Inclusion Bodies 2020 ·Pharmaceutics ·(unknown), Joaquin Seras‐Franzoso, Diana Rafael, Fernanda Andrade, Olivia Cano‐Garrido, (unknown), Estefanía Ugarte-Berzal, Erik Martens, (unknown), Antonio Villaverde, Ghislain Opdenakker, Simó Schwartz, Anna Arı́s, Elena García‐Fruitós	19
17	Engineering a Nanostructured Nucleolin-Binding Peptide for Intracellular Drug Delivery in Triple-Negative Breast Cancer Stem Cells 2019 ·ACS Applied Materials & Interfaces ·Mireia Pesarrodona, Laura Sánchez‐García, Joaquin Seras‐Franzoso, Alejandro Sánchez‐Chardi, (unknown), (unknown), Petra Gener, (unknown), Daniel Pulido, Naroa Serna, Simó Schwartz, Míriam Royo, Antonio Villaverde, Ibane Abasolo, Esther Vázquez	19
18	Efficient bioactive oligonucleotide‐protein conjugation for cell‐targeted cancer therapy 2019 ·ChemistryOpen ·Anna Aviñó, Ugutz Unzueta, María Virtudes Céspedes, Isolda Casanova, Esther Vázquez, Antonio Villaverde, Ramón Mangues, Ramón Eritja	9
19	Recruiting potent membrane penetrability in tumor cell-targeted protein-only nanoparticles 2018 ·Nanotechnology ·Naroa Serna, Julieta M. Sánchez, Ugutz Unzueta, Laura Sánchez‐García, Alejandro Sánchez‐Chardi, Ramón Mangues, Esther Vázquez, Antonio Villaverde	12
20	Overexpression of the nuclear factor kappaB inhibitor A20 is neurotoxic after an excitotoxic injury to the immature rat brain 2013 ·Neurological Research ·Hugo Peluffo, Pau González, Laia Acarín, Anna Arı́s, Rudi Beyaert, Antonio Villaverde, Berta González	6

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact